Targeted therapy for triple-negative breast cancer

25 May 2021


In 2020, 2.3 million women were diagnosed with breast cancer and 685000 breast cancer deaths had occurred globally (World Health Organization). Thankfully, the cancer research does not stop – recently, researchers have developed a novel targeted therapy for triple-negative breast cancer that uses a revolutionary nano-carrier to deliver gambogic acid boosting the effectiveness of existing treatments.


Share